389 articles in this topic
BCG therapy for bladder cancer travels to bone marrow, reprogramming stem cells to produce enhanced immune cells that fight tumors throughout the body.
Study identifies senescent EGR1+ B cells that sabotage immunotherapy in esophageal cancer, with fisetin showing promise as a therapeutic enhancer.
New nanotechnology selectively destroys cancer cell mitochondria, making tumors more vulnerable to T cell attacks across multiple cancer types.
New research reveals how LARP4 protein causes T cells to malfunction in tumors by disrupting cellular energy production.
Researchers integrated brain protein and gene data to identify EGFR, SCFD1, and GMPPB as promising new targets for treating deadly brain cancer.
Multi-omics analysis reveals SASH1 protein loss predicts worse outcomes in head and neck cancer patients and guides targeted therapy selection.
Researchers discover how cancer cells use lysosomes to resist RNA polymerase inhibitors and develop combination strategies to overcome this resistance.
Leading cancer experts reveal breakthrough strategies combining radiation with immune treatments to boost cancer-fighting effectiveness.
New review reveals why fecal microbiota transplants sometimes help—and sometimes hurt—immune checkpoint inhibitor cancer treatments.
Scientists develop bacteria that colonize tumors and secrete proteins to highlight cancer tissue with 15x better contrast than current methods.
New study shows combining PET scans with blood DNA tests can identify follicular lymphoma patients at high risk of early relapse.
Japanese trial shows dual HER2 blockade with pertuzumab plus trastuzumab improves overall survival even after prior pertuzumab treatment.
